Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Viral Genetics Inc. (VRAL)

Total paid for Promotions this month: $85,000
E-mails this Month: 2
Estimated Volume Generated: $269,733
Research Report on VRAL: Click to see
* The information presented is based on information for May , 2012
My new Biotech Blastoff Alert is VRAL - Viral Genetics About VRAL Viral Genetics, Inc., a biotechnology company, discovers and develops immune-based therapies for the treatment of HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. It develops its products using its thymus nuclear protein compound. The company’s product includes VGV-X for the treatment of HIV infection and AIDS. It also develops VGV-L for Lyme ...read more
Promoter: Darth Trader Paying Party: Lake Group Media, Inc.
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $85,000 269,733
Max Profit: 23.75 % Gain at close: -25.00 %
My new Biotech Blastoff Alert is VRAL - Viral Genetics About VRAL Viral Genetics, Inc., a biotechnology company, discovers and develops immune-based therapies for the treatment of HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. It develops its products using its thymus nuclear protein compound. The company’s product includes VGV-X for the treatment of HIV infection and AIDS. It also develops VGV-L for Lyme ...read more
Promoter: The Stock Psycho Paying Party: Lake Group Media, Inc.
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $85,000 269,733
Max Profit: 23.75 % Gain at close: -25.00 %

Turn your attention to VRAL May 22, 2012 07:14

        Viral Genetics’ P-IND Clears FDA To Commence Clinical Trials in Humans Set to Begin First Ovarian Cancer Study Test Site for Metabolic Disruption Technology (MDT) Combination Therapy   A physician-initiated Investigational New Drug (P-IND) application submitted to the FDA in late April, 2012, has cleared the FDA’s screening process with the requirement for a regular IND application being ...read more
Promoter: The Bull Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $15,000 UNKNOWN
Max Profit: 7.39 % Gain at close: Pending

News is out on VRAL Mar 07, 2012 08:56

      News is out on VRAL and Research 2.0 just put out a full report Recent news Viral Genetics Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA http://finance.yahoo.com/news/viral-genetics-submits-pre-ind-133000625.html Research 2.0 New report on VRAL http://www.viralgenetics.com/investors/press-releases/VRAL_REPORT_03062012.pdf BarCharts has a HOLD Rating on VRAL! http://www.barchart.com/quotes/stocks/VRAL   Viral ...read more
Promoter: The Bull Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $15,000 UNKNOWN
Max Profit: 7.39 % Gain at close: Pending

VRAL News Alert..... Feb 02, 2012 11:16

  News Alert on VRAL:       SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011 ...read more
Promoter: SmartPennyInvest.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $2,500 29,248
Max Profit: 27.39 % Gain at close: -10.83 %

VRAL News Alert..... Feb 02, 2012 11:10

  News Alert on VRAL:       SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011 ...read more
Promoter: JumpingPennyStocks.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $2,500 29,248
Max Profit: 27.39 % Gain at close: -10.83 %

VRAL News Alert..... Feb 02, 2012 11:09

  News Alert on VRAL:       SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011 ...read more
Promoter: HotOTCBuzz.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $2,500 29,248
Max Profit: 27.39 % Gain at close: -10.83 %

VRAL News Alert..... Feb 02, 2012 10:51

  News Alert on VRAL:       SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011 ...read more
Promoter: HotPennyInvest.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $2,500 29,248
Max Profit: 27.39 % Gain at close: -10.83 %

VRAL News Alert..... Feb 02, 2012 10:49

  News Alert on VRAL:       SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011 ...read more
Promoter: HotOTCChina.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $2,500 29,248
Max Profit: 27.39 % Gain at close: -10.83 %

VRAL News Alert..... Feb 02, 2012 10:45

  News Alert on VRAL:       SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011 ...read more
Promoter: OTCReporter Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
VRAL $2,500 29,248
Max Profit: 27.39 % Gain at close: -10.83 %
First  >> Last
Video not found or You must install the Flash Plugin for your Browser in order to view this movie